Retrospective exploratory analysis of VEGF polymorphisms in the prediction of benefit from first-line FOLFIRI plus bevacizumab in metastatic colorectal cancer.
Loupakis F, Ruzzo A, Salvatore L, Cremolini C, Masi G, Frumento P, Schirripa M, Catalano V, Galluccio N, Canestrari E, Vincenzi B, Santini D, Bencardino K, Ricci V, Manzoni M, Danova M, Tonini G, Magnani M, Falcone A, Graziano F.
Loupakis F, et al. Among authors: schirripa m.
BMC Cancer. 2011 Jun 14;11:247. doi: 10.1186/1471-2407-11-247.
BMC Cancer. 2011.
PMID: 21669012
Free PMC article.